Ranbaxy/Teva Prohibited From Marketing Generic Quinapril
This article was originally published in The Pink Sheet Daily
Executive Summary
A federal appeals court affirmed a district court decision Nov. 22 that Teva/Ranbaxy's generic quinapril must remain off the market.